Healthcare -
Biotechnology - NASDAQ - US
$ 0.023
-0.87 %
$ 914 K
Market Cap
-0.02
P/E
VIRX - CASH FROM INVESTING ACTIVITIES
Cash from Investing Activities VIRX - Viracta Therapeutics, Inc.
15 M
LAST VALUE
7.86%
2 YEAR CAGR
25.70%
5 YEAR CAGR
-7.36%
10 YEAR CAGR